Pulmonary Fibrosis Patient Registry Data Reveal PF, ILD Outcome Variations
Research based on Pulmonary Fibrosis Foundation Patient Registry data highlight potential disparities in the diagnosis, prognosis, and management of PF and ILD.
Research based on Pulmonary Fibrosis Foundation Patient Registry data highlight potential disparities in the diagnosis, prognosis, and management of PF and ILD.
How do individuals with undiagnosed asthma and COPD manifest these conditions over time, and how do these undiagnosed conditions affect quality of life?
For patients with IPF, how does diagnostic delay affect quality of life as well as hospitalization and progression-free survival rates?
In patients with obesity, what relationships exist between dyspnea in daily living, lung function, and body composition?
Researchers adapted the lung ultrasound score to evaluate bronchopulmonary dysplasia severity and short-term clinical outcomes in preterm infants.
How should clinicians handle the outpatient management of infants, children, and adolescents with post-prematurity respiratory disease? A summary of updated recommendations from the American Thoracic Society offers guidance.
Researchers analyzed the dynamic chest radiography and spirometry in patients with cystic fibrosis before and after starting triple combination CFTR modulator therapy.
How do substance abuse and depression affect the risk for premature mortality in patients with common chronic respiratory and other conditions?
Is combined inhaled corticosteroids/LABA therapy more effective than ICS alone in treating children born with chronic lung disease of prematurity?
Researchers conducted a study to compare the effects of intravenous vs oral antibiotics therapy in patients with a pulmonary infection caused by Pseudomonas aeruginosa secondary to cystic fibrosis.